Christopher Schliehe

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum

Inflammatory Response

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Nature reviews. Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Melisa Daiana Castro Eiro, Kou Hioki, Ling Li, Merel E P Wilmsen, Caoimhe H Kiernan, Inge Brouwers-Haspels, Marjan van Meurs, Manzhi Zhao, Harm de Wit, Dwin G B Grashof, Harmen J G van de Werken, Yvonne M Mueller, Christopher Schliehe, Burcu Temizoz, Kouji Kobiyama, Ken J Ishii, Peter D Katsikis
TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model. Journal of immunology (Baltimore, Md. : 1950) (2023)
Emma G M Tondeur, Jane S A Voerman, Mitchell A A Geleijnse, Laure S van Hofwegen, Anneloes van Krimpen, Julia Koerner, Gunja Mishra, Ziye Song, Christopher Schliehe
Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere-Encapsulated Antigen and a Synthetic Long Peptide In Vitro. Journal of immunology (Baltimore, Md. : 1950) (2023)
Peter D Katsikis, Ken J Ishii, Christopher Schliehe
Challenges in developing personalized neoantigen cancer vaccines. Nature reviews. Immunology (2023)
Kseniya Khamina, Alexander Lercher, Michael Caldera, Christopher Schliehe, Bojan Vilagos, Mehmet Sahin, Lindsay Kosack, Anannya Bhattacharya, Peter Májek, Alexey Stukalov, Roberto Sacco, Leo C James, Daniel D Pinschewer, Keiryn L Bennett, J Formula See Text Rg Menche, Andreas Bergthaler
Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein. PLoS pathogens 13 (12) (2017)